| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogen Sulfide | 35 | 2025 | 77 | 13.240 |
Why?
|
| Nitric Oxide | 52 | 2025 | 381 | 11.780 |
Why?
|
| Aspirin | 34 | 2025 | 88 | 9.740 |
Why?
|
| Neoplasms | 28 | 2024 | 1341 | 6.160 |
Why?
|
| Nitrates | 21 | 2025 | 63 | 5.590 |
Why?
|
| Antineoplastic Agents | 24 | 2024 | 979 | 4.810 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 21 | 2022 | 147 | 4.260 |
Why?
|
| Signal Transduction | 25 | 2024 | 2111 | 3.950 |
Why?
|
| Diabetes Mellitus, Type 2 | 26 | 2025 | 744 | 3.680 |
Why?
|
| Disulfides | 9 | 2020 | 92 | 3.460 |
Why?
|
| Nitric Oxide Donors | 21 | 2025 | 41 | 3.350 |
Why?
|
| Carbon Monoxide | 6 | 2025 | 48 | 2.830 |
Why?
|
| Cell Proliferation | 21 | 2024 | 1420 | 2.660 |
Why?
|
| Nitric Oxide Synthase Type II | 10 | 2025 | 128 | 2.140 |
Why?
|
| NF-kappa B | 11 | 2023 | 355 | 1.920 |
Why?
|
| Animals | 78 | 2025 | 16695 | 1.890 |
Why?
|
| Cyclooxygenase Inhibitors | 6 | 2015 | 34 | 1.730 |
Why?
|
| Humans | 89 | 2025 | 42163 | 1.610 |
Why?
|
| Diabetes Mellitus, Experimental | 12 | 2023 | 126 | 1.600 |
Why?
|
| Parkinson Disease | 2 | 2025 | 207 | 1.590 |
Why?
|
| Receptors, Estrogen | 3 | 2024 | 177 | 1.580 |
Why?
|
| Colonic Neoplasms | 13 | 2015 | 223 | 1.580 |
Why?
|
| Anticholesteremic Agents | 2 | 2023 | 25 | 1.490 |
Why?
|
| Rats, Wistar | 24 | 2025 | 282 | 1.480 |
Why?
|
| beta Catenin | 7 | 2013 | 75 | 1.470 |
Why?
|
| Inflammation | 5 | 2025 | 729 | 1.390 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2024 | 339 | 1.370 |
Why?
|
| Cyclooxygenase 2 | 10 | 2022 | 106 | 1.300 |
Why?
|
| Rats | 35 | 2025 | 3701 | 1.240 |
Why?
|
| Cell Line, Tumor | 19 | 2024 | 2598 | 1.150 |
Why?
|
| Thiones | 3 | 2011 | 5 | 1.110 |
Why?
|
| HT29 Cells | 15 | 2021 | 60 | 1.060 |
Why?
|
| Macrophages | 3 | 2023 | 515 | 1.050 |
Why?
|
| Anticarcinogenic Agents | 5 | 2015 | 74 | 1.050 |
Why?
|
| Apoptosis | 16 | 2024 | 1541 | 1.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2022 | 933 | 0.980 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 5 | 2022 | 26 | 0.970 |
Why?
|
| Obesity | 8 | 2024 | 1131 | 0.960 |
Why?
|
| Eicosanoids | 1 | 2025 | 6 | 0.950 |
Why?
|
| Naproxen | 3 | 2015 | 10 | 0.930 |
Why?
|
| Breast Neoplasms | 4 | 2024 | 1679 | 0.920 |
Why?
|
| Parkinsonian Disorders | 1 | 2025 | 42 | 0.910 |
Why?
|
| Cell Cycle | 12 | 2015 | 348 | 0.900 |
Why?
|
| Cholesterol, LDL | 2 | 2023 | 73 | 0.890 |
Why?
|
| Nerve Degeneration | 1 | 2025 | 108 | 0.890 |
Why?
|
| Glucose | 3 | 2024 | 242 | 0.890 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 90 | 0.880 |
Why?
|
| Growth Inhibitors | 4 | 2011 | 29 | 0.870 |
Why?
|
| Sulindac | 2 | 2015 | 9 | 0.850 |
Why?
|
| Inflammation Mediators | 1 | 2025 | 138 | 0.850 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 5 | 2013 | 43 | 0.820 |
Why?
|
| Carbohydrate Metabolism | 2 | 2020 | 26 | 0.790 |
Why?
|
| Hypercholesterolemia | 1 | 2023 | 42 | 0.780 |
Why?
|
| Neuroprotective Agents | 2 | 2025 | 267 | 0.780 |
Why?
|
| Heat-Shock Proteins | 1 | 2023 | 59 | 0.780 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2022 | 31 | 0.770 |
Why?
|
| Motor Activity | 1 | 2025 | 438 | 0.760 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2020 | 1112 | 0.760 |
Why?
|
| Nanostructures | 1 | 2024 | 158 | 0.760 |
Why?
|
| Mice, Nude | 6 | 2024 | 403 | 0.760 |
Why?
|
| Prodrugs | 3 | 2012 | 31 | 0.750 |
Why?
|
| Muscular Diseases | 1 | 2022 | 22 | 0.740 |
Why?
|
| Reactive Oxygen Species | 7 | 2024 | 518 | 0.700 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 99 | 0.690 |
Why?
|
| Myocardial Reperfusion Injury | 4 | 2023 | 51 | 0.690 |
Why?
|
| Lipoproteins | 1 | 2021 | 68 | 0.690 |
Why?
|
| Gastric Mucosa | 4 | 2021 | 64 | 0.680 |
Why?
|
| Neoplasms, Experimental | 2 | 2021 | 38 | 0.660 |
Why?
|
| Chemoprevention | 4 | 2015 | 41 | 0.640 |
Why?
|
| Gluconeogenesis | 4 | 2025 | 15 | 0.640 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 71 | 0.630 |
Why?
|
| Pancreatic Neoplasms | 3 | 2020 | 206 | 0.630 |
Why?
|
| Cyclooxygenase 1 | 3 | 2015 | 13 | 0.620 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2025 | 184 | 0.560 |
Why?
|
| Hypertension | 2 | 2022 | 823 | 0.560 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 137 | 0.550 |
Why?
|
| Sulfides | 4 | 2023 | 77 | 0.540 |
Why?
|
| Antioxidants | 3 | 2023 | 439 | 0.540 |
Why?
|
| Azo Compounds | 2 | 2023 | 17 | 0.530 |
Why?
|
| Sodium Nitrite | 3 | 2021 | 4 | 0.530 |
Why?
|
| Transcription Factors | 4 | 2010 | 722 | 0.530 |
Why?
|
| Liver | 5 | 2025 | 503 | 0.520 |
Why?
|
| Mice | 14 | 2024 | 6490 | 0.520 |
Why?
|
| Brain | 1 | 2024 | 1452 | 0.510 |
Why?
|
| Inhibitory Concentration 50 | 5 | 2015 | 98 | 0.490 |
Why?
|
| Male | 27 | 2025 | 22779 | 0.470 |
Why?
|
| Nitrites | 5 | 2023 | 54 | 0.460 |
Why?
|
| Dinoprostone | 4 | 2022 | 69 | 0.460 |
Why?
|
| Oxidative Stress | 4 | 2025 | 990 | 0.460 |
Why?
|
| Hypoglycemic Agents | 3 | 2025 | 181 | 0.440 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1066 | 0.440 |
Why?
|
| Citrulline | 3 | 2024 | 14 | 0.430 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2011 | 18 | 0.430 |
Why?
|
| Receptor, erbB-2 | 1 | 2015 | 149 | 0.420 |
Why?
|
| Caspase 3 | 4 | 2020 | 226 | 0.420 |
Why?
|
| Structure-Activity Relationship | 7 | 2021 | 491 | 0.420 |
Why?
|
| Glutathione Transferase | 2 | 2011 | 90 | 0.420 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2011 | 10 | 0.420 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2010 | 20 | 0.420 |
Why?
|
| Wound Healing | 3 | 2024 | 82 | 0.410 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2013 | 8 | 0.410 |
Why?
|
| Flurbiprofen | 1 | 2013 | 11 | 0.410 |
Why?
|
| Molecular Structure | 5 | 2015 | 560 | 0.410 |
Why?
|
| Osteoporosis | 2 | 2025 | 48 | 0.400 |
Why?
|
| Morpholines | 1 | 2013 | 73 | 0.400 |
Why?
|
| Diabetes Mellitus | 3 | 2025 | 532 | 0.390 |
Why?
|
| Wnt Proteins | 2 | 2010 | 23 | 0.390 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2025 | 85 | 0.390 |
Why?
|
| Chimera | 1 | 2012 | 18 | 0.390 |
Why?
|
| Oxidation-Reduction | 3 | 2024 | 448 | 0.390 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2020 | 74 | 0.390 |
Why?
|
| Exercise | 1 | 2019 | 674 | 0.390 |
Why?
|
| Ibuprofen | 2 | 2012 | 34 | 0.390 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 1554 | 0.390 |
Why?
|
| Nitric Oxide Synthase | 6 | 2021 | 134 | 0.390 |
Why?
|
| Adipose Tissue | 3 | 2024 | 180 | 0.380 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2011 | 5 | 0.370 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2011 | 3 | 0.370 |
Why?
|
| Intracellular Membranes | 2 | 2011 | 37 | 0.370 |
Why?
|
| Cell Communication | 1 | 2013 | 110 | 0.370 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2011 | 52 | 0.360 |
Why?
|
| Hyperalgesia | 3 | 2020 | 23 | 0.360 |
Why?
|
| Cystathionine gamma-Lyase | 3 | 2020 | 15 | 0.360 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 187 | 0.360 |
Why?
|
| Glioblastoma | 2 | 2023 | 69 | 0.350 |
Why?
|
| Membrane Microdomains | 1 | 2011 | 53 | 0.350 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2011 | 89 | 0.350 |
Why?
|
| S-Nitrosothiols | 1 | 2010 | 4 | 0.340 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 9 | 0.340 |
Why?
|
| Hydrazines | 1 | 2010 | 23 | 0.330 |
Why?
|
| Adipose Tissue, Brown | 2 | 2022 | 39 | 0.330 |
Why?
|
| Leukemia, T-Cell | 1 | 2010 | 6 | 0.330 |
Why?
|
| Jurkat Cells | 4 | 2013 | 84 | 0.320 |
Why?
|
| Cystathionine beta-Synthase | 2 | 2020 | 16 | 0.320 |
Why?
|
| Piperazines | 1 | 2010 | 117 | 0.320 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 502 | 0.310 |
Why?
|
| Cytoskeletal Proteins | 3 | 2005 | 114 | 0.310 |
Why?
|
| Trans-Activators | 3 | 2005 | 190 | 0.300 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2021 | 147 | 0.300 |
Why?
|
| Astrocytes | 2 | 2024 | 244 | 0.280 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2023 | 52 | 0.280 |
Why?
|
| Tumor Burden | 2 | 2020 | 84 | 0.270 |
Why?
|
| Female | 18 | 2024 | 24018 | 0.260 |
Why?
|
| Arginine | 3 | 2023 | 75 | 0.260 |
Why?
|
| Isomerism | 4 | 2013 | 65 | 0.250 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2019 | 167 | 0.240 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 557 | 0.240 |
Why?
|
| Sophora | 1 | 2025 | 1 | 0.240 |
Why?
|
| Oxidopamine | 1 | 2025 | 23 | 0.230 |
Why?
|
| Edema | 3 | 2015 | 26 | 0.220 |
Why?
|
| Fasting | 1 | 2024 | 56 | 0.220 |
Why?
|
| Glycolysis | 1 | 2024 | 71 | 0.220 |
Why?
|
| Thioredoxin-Disulfide Reductase | 2 | 2015 | 7 | 0.210 |
Why?
|
| Metformin | 1 | 2025 | 74 | 0.210 |
Why?
|
| Sericins | 1 | 2023 | 1 | 0.210 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2023 | 4 | 0.200 |
Why?
|
| Genes, Reporter | 3 | 2015 | 148 | 0.200 |
Why?
|
| Malondialdehyde | 2 | 2015 | 42 | 0.200 |
Why?
|
| Clinical Trials as Topic | 2 | 2022 | 249 | 0.200 |
Why?
|
| Anniversaries and Special Events | 1 | 2023 | 6 | 0.200 |
Why?
|
| Fever | 2 | 2015 | 63 | 0.200 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2023 | 54 | 0.190 |
Why?
|
| Adipose Tissue, White | 2 | 2022 | 18 | 0.190 |
Why?
|
| Renin-Angiotensin System | 1 | 2022 | 44 | 0.190 |
Why?
|
| Melatonin | 1 | 2023 | 83 | 0.190 |
Why?
|
| Behavior, Animal | 1 | 2025 | 369 | 0.190 |
Why?
|
| Superoxide Dismutase | 2 | 2015 | 158 | 0.190 |
Why?
|
| Kidney | 2 | 2023 | 363 | 0.190 |
Why?
|
| Isoenzymes | 3 | 2025 | 169 | 0.190 |
Why?
|
| Mevalonic Acid | 1 | 2022 | 9 | 0.190 |
Why?
|
| Proliferating Cell Nuclear Antigen | 3 | 2015 | 49 | 0.190 |
Why?
|
| Stomach Ulcer | 2 | 2013 | 8 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2023 | 168 | 0.180 |
Why?
|
| Plant Extracts | 1 | 2025 | 303 | 0.180 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 160 | 0.180 |
Why?
|
| Anhydrides | 1 | 2021 | 1 | 0.180 |
Why?
|
| Cell Division | 5 | 2005 | 314 | 0.180 |
Why?
|
| Intestinal Absorption | 1 | 2021 | 22 | 0.180 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 129 | 0.180 |
Why?
|
| Hyperuricemia | 1 | 2021 | 13 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 206 | 0.180 |
Why?
|
| Uric Acid | 1 | 2021 | 29 | 0.180 |
Why?
|
| Drug Synergism | 1 | 2022 | 189 | 0.180 |
Why?
|
| Biology | 1 | 2021 | 20 | 0.180 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 228 | 0.170 |
Why?
|
| Citric Acid | 1 | 2021 | 14 | 0.170 |
Why?
|
| Insulin | 5 | 2021 | 255 | 0.170 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 74 | 0.170 |
Why?
|
| Adiposity | 2 | 2021 | 155 | 0.170 |
Why?
|
| Prediabetic State | 1 | 2022 | 68 | 0.170 |
Why?
|
| Medicine | 1 | 2021 | 37 | 0.170 |
Why?
|
| Animal Experimentation | 1 | 2020 | 3 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 60 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2022 | 189 | 0.170 |
Why?
|
| Muscle, Skeletal | 2 | 2023 | 308 | 0.170 |
Why?
|
| Amino Acids | 1 | 2021 | 150 | 0.170 |
Why?
|
| Gold | 1 | 2022 | 153 | 0.160 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2020 | 1 | 0.160 |
Why?
|
| Thiazolidinediones | 1 | 2020 | 49 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2013 | 379 | 0.160 |
Why?
|
| Mitochondria, Liver | 3 | 2011 | 15 | 0.160 |
Why?
|
| Agrochemicals | 1 | 2020 | 6 | 0.160 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2020 | 13 | 0.160 |
Why?
|
| Cardiotonic Agents | 1 | 2020 | 39 | 0.160 |
Why?
|
| Medicago sativa | 1 | 2020 | 9 | 0.160 |
Why?
|
| Congresses as Topic | 1 | 2020 | 49 | 0.160 |
Why?
|
| Curcumin | 1 | 2021 | 115 | 0.160 |
Why?
|
| Pain Threshold | 1 | 2020 | 34 | 0.160 |
Why?
|
| Neurons | 2 | 2024 | 1246 | 0.160 |
Why?
|
| Macrophage Activation | 1 | 2020 | 59 | 0.160 |
Why?
|
| Mice, SCID | 1 | 2020 | 158 | 0.160 |
Why?
|
| Cysteine | 1 | 2020 | 101 | 0.160 |
Why?
|
| Neuralgia | 1 | 2020 | 21 | 0.160 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 261 | 0.160 |
Why?
|
| Streptozocin | 4 | 2020 | 26 | 0.150 |
Why?
|
| Energy Metabolism | 1 | 2020 | 181 | 0.150 |
Why?
|
| RNA, Messenger | 5 | 2023 | 1265 | 0.150 |
Why?
|
| Sulfurtransferases | 1 | 2019 | 2 | 0.150 |
Why?
|
| Insulin Resistance | 1 | 2021 | 199 | 0.150 |
Why?
|
| Hyperthyroidism | 1 | 2019 | 8 | 0.150 |
Why?
|
| Spinal Cord | 1 | 2020 | 109 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 297 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 189 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2020 | 301 | 0.140 |
Why?
|
| Research Design | 1 | 2020 | 370 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2018 | 21 | 0.140 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2019 | 142 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2023 | 449 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2018 | 37 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 51 | 0.130 |
Why?
|
| Gene Expression | 2 | 2023 | 692 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 76 | 0.130 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 350 | 0.130 |
Why?
|
| Microglia | 2 | 2023 | 204 | 0.130 |
Why?
|
| Stereoisomerism | 2 | 2015 | 166 | 0.130 |
Why?
|
| Luciferases | 2 | 2015 | 70 | 0.130 |
Why?
|
| Hippocampus | 1 | 2020 | 591 | 0.130 |
Why?
|
| Mitochondria | 1 | 2020 | 516 | 0.130 |
Why?
|
| Myocardium | 1 | 2019 | 251 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2018 | 170 | 0.120 |
Why?
|
| Cytokines | 1 | 2020 | 661 | 0.120 |
Why?
|
| Glucose Tolerance Test | 3 | 2022 | 76 | 0.120 |
Why?
|
| Platelet Aggregation | 1 | 2015 | 21 | 0.120 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 35 | 0.120 |
Why?
|
| Sheep | 1 | 2015 | 77 | 0.120 |
Why?
|
| Analgesics | 1 | 2015 | 55 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 67 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 77 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2015 | 256 | 0.110 |
Why?
|
| Models, Molecular | 2 | 2020 | 875 | 0.110 |
Why?
|
| Blood Glucose | 3 | 2022 | 386 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 3 | 2004 | 506 | 0.110 |
Why?
|
| Time Factors | 2 | 2015 | 1848 | 0.100 |
Why?
|
| Membrane Proteins | 3 | 2005 | 548 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2013 | 5 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2019 | 452 | 0.100 |
Why?
|
| Adenocarcinoma | 2 | 2005 | 287 | 0.100 |
Why?
|
| Bone Density | 2 | 2025 | 102 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 522 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 972 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2013 | 462 | 0.090 |
Why?
|
| Cyclic GMP | 3 | 2023 | 55 | 0.090 |
Why?
|
| Peptic Ulcer | 1 | 2012 | 15 | 0.090 |
Why?
|
| Enzyme Induction | 2 | 2009 | 53 | 0.090 |
Why?
|
| Cell Survival | 1 | 2015 | 934 | 0.090 |
Why?
|
| Sodium Fluoride | 1 | 2011 | 11 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 94 | 0.090 |
Why?
|
| Glucuronosyltransferase | 1 | 2011 | 29 | 0.090 |
Why?
|
| Autophagy | 1 | 2013 | 136 | 0.090 |
Why?
|
| Acetylation | 1 | 2011 | 108 | 0.090 |
Why?
|
| Cardiolipins | 1 | 2011 | 12 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2023 | 385 | 0.080 |
Why?
|
| Phospholipids | 1 | 2011 | 69 | 0.080 |
Why?
|
| Nitroso Compounds | 1 | 2010 | 12 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 458 | 0.080 |
Why?
|
| Transcription Factor RelA | 1 | 2010 | 41 | 0.080 |
Why?
|
| Stomach | 1 | 2010 | 50 | 0.080 |
Why?
|
| Risk Factors | 1 | 2019 | 3942 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2011 | 134 | 0.080 |
Why?
|
| Aged | 1 | 2022 | 7982 | 0.080 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 141 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2009 | 44 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2010 | 154 | 0.080 |
Why?
|
| RNA Interference | 1 | 2010 | 246 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2009 | 599 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2010 | 884 | 0.070 |
Why?
|
| Biological Products | 1 | 2009 | 91 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 457 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 683 | 0.060 |
Why?
|
| Linoleic Acid | 1 | 2005 | 9 | 0.060 |
Why?
|
| Palmitoylcarnitine | 1 | 2005 | 1 | 0.060 |
Why?
|
| Arachidonic Acid | 1 | 2005 | 35 | 0.060 |
Why?
|
| Lactones | 1 | 2005 | 22 | 0.060 |
Why?
|
| Sulfones | 1 | 2005 | 47 | 0.060 |
Why?
|
| Caspases | 1 | 2005 | 148 | 0.050 |
Why?
|
| Genes, APC | 1 | 2004 | 15 | 0.050 |
Why?
|
| Animals, Laboratory | 1 | 2023 | 3 | 0.050 |
Why?
|
| Weight Loss | 1 | 2024 | 138 | 0.050 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2004 | 23 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2024 | 99 | 0.050 |
Why?
|
| Leukemoid Reaction | 1 | 2023 | 1 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2021 | 1737 | 0.050 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2023 | 82 | 0.050 |
Why?
|
| Down Syndrome | 1 | 2023 | 31 | 0.050 |
Why?
|
| Progesterone | 1 | 2023 | 120 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2023 | 128 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2005 | 211 | 0.050 |
Why?
|
| I-kappa B Kinase | 1 | 2023 | 50 | 0.050 |
Why?
|
| Infarction | 1 | 2022 | 2 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2022 | 55 | 0.050 |
Why?
|
| Bone Resorption | 1 | 2021 | 22 | 0.050 |
Why?
|
| Drug Carriers | 1 | 2023 | 169 | 0.050 |
Why?
|
| Iran | 1 | 2022 | 199 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 29 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2023 | 137 | 0.040 |
Why?
|
| Gastric Juice | 1 | 2021 | 3 | 0.040 |
Why?
|
| DNA Repair | 1 | 2023 | 196 | 0.040 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2021 | 3 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2023 | 183 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2021 | 23 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2021 | 30 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 2021 | 33 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2021 | 144 | 0.040 |
Why?
|
| Arginase | 1 | 2020 | 14 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 273 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 99 | 0.040 |
Why?
|
| Models, Animal | 1 | 2021 | 149 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2021 | 80 | 0.040 |
Why?
|
| Species Specificity | 1 | 2021 | 279 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 2020 | 49 | 0.040 |
Why?
|
| Naphthyridines | 1 | 2020 | 5 | 0.040 |
Why?
|
| Benzoxazoles | 1 | 2020 | 10 | 0.040 |
Why?
|
| Carbachol | 1 | 2020 | 19 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 178 | 0.040 |
Why?
|
| Water | 1 | 2022 | 314 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 180 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 82 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2023 | 973 | 0.040 |
Why?
|
| Acclimatization | 1 | 2020 | 25 | 0.040 |
Why?
|
| Skin | 1 | 2021 | 185 | 0.040 |
Why?
|
| Urea | 1 | 2020 | 44 | 0.040 |
Why?
|
| Droughts | 1 | 2020 | 29 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2020 | 136 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2020 | 57 | 0.040 |
Why?
|
| Homeostasis | 1 | 2021 | 193 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2020 | 101 | 0.040 |
Why?
|
| Isoquinolines | 1 | 2020 | 50 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 698 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2020 | 141 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2019 | 21 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 134 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2020 | 170 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2021 | 324 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 1188 | 0.030 |
Why?
|
| Binding Sites | 2 | 2012 | 670 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1076 | 0.030 |
Why?
|
| Bystander Effect | 1 | 2015 | 15 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 285 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 662 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 810 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 200 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 711 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2013 | 24 | 0.030 |
Why?
|
| Astrocytoma | 1 | 2013 | 16 | 0.030 |
Why?
|
| Molecular Conformation | 2 | 2005 | 157 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 105 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 165 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2013 | 268 | 0.020 |
Why?
|
| Phenylethyl Alcohol | 1 | 2012 | 3 | 0.020 |
Why?
|
| Indomethacin | 1 | 2012 | 26 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 235 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2005 | 1804 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 1617 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2006 | 11 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 43 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2006 | 56 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 56 | 0.020 |
Why?
|
| Pancreas | 1 | 2006 | 45 | 0.020 |
Why?
|
| Cricetinae | 1 | 2006 | 241 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 98 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 13458 | 0.010 |
Why?
|
| Carcinogens | 1 | 2006 | 126 | 0.010 |
Why?
|
| Catalysis | 1 | 2005 | 191 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 295 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 201 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 2004 | 71 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2004 | 25 | 0.010 |
Why?
|
| TCF Transcription Factors | 1 | 2003 | 17 | 0.010 |
Why?
|
| Colon | 1 | 2004 | 118 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 997 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2003 | 92 | 0.010 |
Why?
|
| Cadherins | 1 | 2003 | 102 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 131 | 0.010 |
Why?
|
| Proteins | 1 | 2005 | 383 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 574 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 526 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 428 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 383 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 658 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 928 | 0.010 |
Why?
|
| Cell Death | 1 | 2002 | 277 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2004 | 426 | 0.010 |
Why?
|